SCHEMBL4668740

SCHEMBL4668740

CS(=O)(=O)C1CNCCN1CC1CO1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.35
HBB P68871 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477212 0.77
SCHEMBL11002350 0.75 TP53 (0.36) TP53HBBSMN1; SMN2
SCHEMBL477224 0.74
SCHEMBL8248622 0.74 CA1 (0.33)
SCHEMBL5603511 0.73 TP53 (0.35) TP53HBBSMN1; SMN2
SCHEMBL4667961 0.73 TP53 (0.36) TP53HBBSMN1; SMN2
SCHEMBL17004650 0.73
SCHEMBL23142611 0.72
SCHEMBL23142616 0.71 POLB (0.42) SMN1; SMN2
SCHEMBL10570095 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902053-A2 BENZOIMIDAZOLONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Theravance, Inc. (US) 2008-03-26 EP disclosed
WO-2006133104-A2 BENZOIMIDAZOLONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS THERAVANCE, INC. (US) 2006-12-14 WO disclosed